These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

378 related items for PubMed ID: 28522744

  • 21. 2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma.
    Swisher SG, Erasmus J, Maish M, Correa AM, Macapinlac H, Ajani JA, Cox JD, Komaki RR, Hong D, Lee HK, Putnam JB, Rice DC, Smythe WR, Thai L, Vaporciyan AA, Walsh GL, Wu TT, Roth JA.
    Cancer; 2004 Oct 15; 101(8):1776-85. PubMed ID: 15386332
    [Abstract] [Full Text] [Related]

  • 22. Prognostic value of metabolic response measured by 18F-FDG-PET in oesophageal cancer patients treated with definitive chemoradiotherapy.
    Onal C, Torun N, Guler OC, Yildirim BA.
    Nucl Med Commun; 2016 Dec 15; 37(12):1282-1289. PubMed ID: 27612030
    [Abstract] [Full Text] [Related]

  • 23. Results of the baseline positron emission tomography can customize therapy of localized esophageal adenocarcinoma patients who achieve a clinical complete response after chemoradiation.
    Suzuki A, Xiao L, Taketa T, Sudo K, Wadhwa R, Blum MA, Skinner H, Komaki R, Weston B, Lee JH, Bhutani MS, Rice DC, Maru DM, Erasmus J, Swisher SG, Hofstetter WL, Ajani JA.
    Ann Oncol; 2013 Nov 15; 24(11):2854-9. PubMed ID: 23994746
    [Abstract] [Full Text] [Related]

  • 24. Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer.
    Swisher SG, Maish M, Erasmus JJ, Correa AM, Ajani JA, Bresalier R, Komaki R, Macapinlac H, Munden RF, Putnam JB, Rice D, Smythe WR, Vaporciyan AA, Walsh GL, Wu TT, Roth JA.
    Ann Thorac Surg; 2004 Oct 15; 78(4):1152-60; discussion 1152-60. PubMed ID: 15464463
    [Abstract] [Full Text] [Related]

  • 25. Sequential FDG-PET and induction chemotherapy in locally advanced adenocarcinoma of the Oesophago-gastric junction (AEG): the Heidelberg Imaging program in Cancer of the oesophago-gastric junction during Neoadjuvant treatment: HICON trial.
    Lorenzen S, von Gall C, Stange A, Haag GM, Weitz J, Haberkorn U, Lordick F, Weichert W, Abel U, Debus J, Jäger D, Münter MW.
    BMC Cancer; 2011 Jun 24; 11():266. PubMed ID: 21702914
    [Abstract] [Full Text] [Related]

  • 26. Positron-Emission Tomography Scan-Directed Chemoradiation for Esophageal Squamous Cell Carcinoma: No Benefit for a Change in Chemotherapy in Positron-Emission Tomography Nonresponders.
    Greally M, Chou JF, Molena D, Rusch VW, Bains MS, Park BJ, Wu AJ, Goodman KA, Kelsen DP, Janjigian YY, Ilson DH, Ku GY.
    J Thorac Oncol; 2019 Mar 24; 14(3):540-546. PubMed ID: 30391577
    [Abstract] [Full Text] [Related]

  • 27. Predictive value of 18-fluoro-deoxy-glucose-positron emission tomography (18F-FDG-PET) in the identification of responders to chemoradiation therapy for the treatment of locally advanced esophageal cancer.
    Levine EA, Farmer MR, Clark P, Mishra G, Ho C, Geisinger KR, Melin SA, Lovato J, Oaks T, Blackstock AW.
    Ann Surg; 2006 Apr 24; 243(4):472-8. PubMed ID: 16552197
    [Abstract] [Full Text] [Related]

  • 28. Predictive value of repeated F-18 FDG PET/CT parameters changes during preoperative chemoradiotherapy to predict pathologic response and overall survival in locally advanced esophageal adenocarcinoma patients.
    Kim SJ, Koo PJ, Chang S.
    Cancer Chemother Pharmacol; 2016 Apr 24; 77(4):723-31. PubMed ID: 26891957
    [Abstract] [Full Text] [Related]

  • 29. [18F]-Fluorodeoxyglucose-positron emission tomography for the assessment of histopathologic response and prognosis after completion of neoadjuvant chemoradiation in esophageal cancer.
    Vallböhmer D, Hölscher AH, Dietlein M, Bollschweiler E, Baldus SE, Mönig SP, Metzger R, Schicha H, Schmidt M.
    Ann Surg; 2009 Dec 24; 250(6):888-94. PubMed ID: 19953708
    [Abstract] [Full Text] [Related]

  • 30. Favorable versus unfavorable prognostic groups by post-chemoradiation FDG-PET imaging in node-positive esophageal squamous cell carcinoma patients treated with definitive chemoradiotherapy.
    Yap WK, Chang YC, Hsieh CH, Chao YK, Chen CC, Shih MC, Hung TM.
    Eur J Nucl Med Mol Imaging; 2018 May 24; 45(5):689-698. PubMed ID: 29188300
    [Abstract] [Full Text] [Related]

  • 31. Value of baseline positron emission tomography for predicting overall survival in patient with nonmetastatic esophageal or gastroesophageal junction carcinoma.
    Hong D, Lunagomez S, Kim EE, Lee JH, Bresalier RS, Swisher SG, Wu TT, Morris J, Liao Z, Komaki R, Ajani JA.
    Cancer; 2005 Oct 15; 104(8):1620-6. PubMed ID: 16118804
    [Abstract] [Full Text] [Related]

  • 32. Intratumor Textural Heterogeneity on Pretreatment (18)F-FDG PET Images Predicts Response and Survival After Chemoradiotherapy for Hypopharyngeal Cancer.
    Oh JS, Kang BC, Roh JL, Kim JS, Cho KJ, Lee SW, Kim SB, Choi SH, Nam SY, Kim SY.
    Ann Surg Oncol; 2015 Aug 15; 22(8):2746-54. PubMed ID: 25487968
    [Abstract] [Full Text] [Related]

  • 33. Evaluation of ¹⁸F-FDG-PET for early detection of suboptimal response of rectal cancer to preoperative chemoradiotherapy: a prospective analysis.
    Leibold T, Akhurst TJ, Chessin DB, Yeung HW, Macapinlac H, Shia J, Minsky BD, Saltz LB, Riedel E, Mazumdar M, Paty PB, Weiser MR, Wong WD, Larson SM, Guillem JG.
    Ann Surg Oncol; 2011 Oct 15; 18(10):2783-9. PubMed ID: 21476107
    [Abstract] [Full Text] [Related]

  • 34. Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment.
    Wieder HA, Brücher BL, Zimmermann F, Becker K, Lordick F, Beer A, Schwaiger M, Fink U, Siewert JR, Stein HJ, Weber WA.
    J Clin Oncol; 2004 Mar 01; 22(5):900-8. PubMed ID: 14990646
    [Abstract] [Full Text] [Related]

  • 35. Locally advanced esophageal adenocarcinoma: response to neoadjuvant chemotherapy and survival predicted by ([18F])FDG-PET/CT.
    Kauppi JT, Oksala N, Salo JA, Helin H, Karhumäki L, Kemppainen J, Sihvo EI, Räsänen JV.
    Acta Oncol; 2012 May 01; 51(5):636-44. PubMed ID: 22208782
    [Abstract] [Full Text] [Related]

  • 36. The Role of 18-Fluoro-2-Deoxy-Glucose Positron Emission Tomography/Computed Tomography as Response and Prognosis Predictive Factor of Concurrent Chemoradiotherapy after Induction Chemotherapy in Head and Neck Squamous Cell Carcinoma: A Prospective Study.
    Šedienė S, Kulakienė I, Rudžianskas V, Ambrazienė R.
    Medicina (Kaunas); 2018 May 15; 54(2):. PubMed ID: 30344262
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. To evaluate the treatment response of locally advanced esophageal cancer after preoperative chemoradiotherapy by FDG-PET/CT scan.
    Huang JW, Yeh HL, Hsu CP, Lu YY, Chuang CY, Lin JC, Lin JF, Chang CF.
    J Chin Med Assoc; 2015 Apr 15; 78(4):229-34. PubMed ID: 25557468
    [Abstract] [Full Text] [Related]

  • 39. (18)F-FDG PET-guided salvage neoadjuvant radiochemotherapy of adenocarcinoma of the esophagogastric junction: the MUNICON II trial.
    zum Büschenfelde CM, Herrmann K, Schuster T, Geinitz H, Langer R, Becker K, Ott K, Ebert M, Zimmermann F, Friess H, Schwaiger M, Peschel C, Lordick F, Krause BJ.
    J Nucl Med; 2011 Aug 15; 52(8):1189-96. PubMed ID: 21764790
    [Abstract] [Full Text] [Related]

  • 40. Preoperative Prediction of Pathologic Response to Neoadjuvant Chemoradiotherapy in Patients With Esophageal Cancer Using 18F-FDG PET/CT and DW-MRI: A Prospective Multicenter Study.
    Borggreve AS, Goense L, van Rossum PSN, Heethuis SE, van Hillegersberg R, Lagendijk JJW, Lam MGEH, van Lier ALHMW, Mook S, Ruurda JP, van Vulpen M, Voncken FEM, Aleman BMP, Bartels-Rutten A, Ma J, Fang P, Musall BC, Lin SH, Meijer GJ.
    Int J Radiat Oncol Biol Phys; 2020 Apr 01; 106(5):998-1009. PubMed ID: 31987972
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.